
CPHI Milan 2026
Fiera Milano, Italy
6 – 8 October, 2026
Booth: 3F103
From complex intermediates to finished APIs, we deliver quality products across therapeutic areas with world-class manufacturing capabilities.

APIs, or Active Pharmaceutical Ingredients, are the components in a pharmaceutical drug that produce the intended therapeutic effect. Our portfolio spans 55 commercial APIs manufactured under stringent quality systems for global pharmaceutical companies.
View APIs →
Pharmaceutical intermediates serve as building blocks used during API production. They are used solely in the synthesis of APIs and are not directly administered to patients.
View Intermediates →
Pellets are small, free-flowing, spherical particles made by combining fine powders or granules of drugs and excipients — value-added, semi-finished formulations for novel drug delivery systems.
View Pellets →
Piperidines are among the most important synthetic fragments for designing drugs and play a significant role in the pharmaceutical industry. Cost-effective processes for these derivatives are our core expertise.
View Derivatives →
Under-development APIs are driven by pharmaceutical innovation, enabling us to meet dynamic healthcare demands and emerging treatment challenges.
View pipeline →
VPCL offers long-term contract manufacturing services — from strategic partnerships in development and validations to DMF filing and commercial manufacturing.
Read more →Inspect pharmaceutical molecules across our entire product portfolio in real-time stereochemical 3D. Rotate, zoom, and analyze molecular geometry, bond angles, and regulatory monographs.